Clinical, Immunological, and Molecular Variability of RAG Deficiency: A Retrospective Analysis of 22 RAG Patients

[1]  M. van der Burg,et al.  The Clinical and Genetic Spectrum of 82 Patients With RAG Deficiency Including a c.256_257delAA Founder Variant in Slavic Countries , 2020, Frontiers in Immunology.

[2]  A. Simon,et al.  A Large Cohort of RAG1/2-Deficient SCID Patients—Clinical, Immunological, and Prognostic Analysis , 2019, Journal of Clinical Immunology.

[3]  F. Rieux-Laucat,et al.  Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes. , 2019, Blood.

[4]  A. Fischer,et al.  Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Primary Immunodeficiencies and Inherited Disorders in Children. , 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[5]  L. Notarangelo,et al.  Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency. , 2019, The journal of allergy and clinical immunology. In practice.

[6]  D. Lazarević,et al.  Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies , 2019, Front. Immunol..

[7]  L. Notarangelo,et al.  RAG gene defects at the verge of immunodeficiency and immune dysregulation , 2018, Immunological reviews.

[8]  M. van der Burg,et al.  Phenotypical heterogeneity in RAG‐deficient patients from a highly consanguineous population , 2018, Clinical and experimental immunology.

[9]  L. Notarangelo,et al.  RAG Deficiency: Two Genes, Many Diseases , 2018, Journal of Clinical Immunology.

[10]  Sri V. V. Deevi,et al.  Prevalence and clinical challenges among adults with primary immunodeficiency and recombination-activating gene deficiency. , 2018, The Journal of allergy and clinical immunology.

[11]  L. Notarangelo,et al.  DNA recombination defects in Kuwait: Clinical, immunologic and genetic profile , 2017, Clinical Immunology.

[12]  L. Notarangelo,et al.  Agammaglobulinemia associated to nasal polyposis due to a hypomorphic RAG1 mutation in a 12 years old boy. , 2016, Clinical Immunology.

[13]  L. Notarangelo,et al.  Human RAG mutations: biochemistry and clinical implications , 2016, Nature Reviews Immunology.

[14]  E. Brooks,et al.  Newborn Screening for Severe Combined Immunodeficiency in 11 Screening Programs in the United States , 2015, Pediatrics.

[15]  J. B. Oliveira,et al.  Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency. , 2015, The Journal of clinical investigation.

[16]  M. Eibl,et al.  Leaky RAG Deficiency in Adult Patients with Impaired Antibody Production against Bacterial Polysaccharide Antigens , 2015, PloS one.

[17]  O. Ohara,et al.  RAG1 Deficiency May Present Clinically as Selective IgA Deficiency , 2015, Journal of Clinical Immunology.

[18]  L. Notarangelo,et al.  Immune deficiencies, infection, and systemic immune disordersComparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency , 2014 .

[19]  C. Cancrini,et al.  HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders. , 2014, Blood.

[20]  L. Notarangelo,et al.  Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience. , 2014, The Journal of allergy and clinical immunology.

[21]  M. Yandell,et al.  Autoimmunity due to RAG deficiency and estimated disease incidence in RAG1/2 mutations. , 2014, The Journal of allergy and clinical immunology.

[22]  F. Alt,et al.  A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency. , 2013, The Journal of allergy and clinical immunology.

[23]  L. Notarangelo,et al.  Expanding the spectrum of recombination-activating gene 1 deficiency: a family with early-onset autoimmunity. , 2013, The Journal of allergy and clinical immunology.

[24]  L. Notarangelo,et al.  A novel homozygous mutation in recombination activating gene 2 in 2 relatives with different clinical phenotypes: Omenn syndrome and hyper-IgM syndrome. , 2012, The Journal of allergy and clinical immunology.

[25]  B. Helmink,et al.  The response to and repair of RAG-mediated DNA double-strand breaks. , 2012, Annual review of immunology.

[26]  Amos Etzioni,et al.  Novel mutations in RAG1/2 and ADA genes in Israeli patients presenting with T-B-SCID or Omenn syndrome. , 2011, Clinical immunology.

[27]  M. van der Burg,et al.  Idiopathic CD4+ T lymphopenia without autoimmunity or granulomatous disease in the slipstream of RAG mutations. , 2011, Blood.

[28]  F. Alt,et al.  Hypomorphic Rag mutations can cause destructive midline granulomatous disease. , 2010, Blood.

[29]  F. Alt,et al.  Expansion of immunoglobulin-secreting cells and defects in B cell tolerance in Rag-dependent immunodeficiency , 2010, The Journal of experimental medicine.

[30]  M. van der Burg,et al.  Homeostatic expansion of autoreactive immunoglobulin-secreting cells in the Rag2 mouse model of Omenn syndrome , 2010, The Journal of experimental medicine.

[31]  P. Cortés,et al.  Analysis of mutations from SCID and Omenn syndrome patients reveals the central role of the Rag2 PHD domain in regulating V(D)J recombination. , 2010, The Journal of clinical investigation.

[32]  S. Djuricic,et al.  Recombinase‐activating gene 1 immunodeficiency: different immunological phenotypes in three siblings , 2009, Acta paediatrica.

[33]  U. Pannicke,et al.  An immunodeficiency disease with RAG mutations and granulomas. , 2008, The New England journal of medicine.

[34]  A. Villa,et al.  RAG‐dependent primary immunodeficiencies , 2006, Human mutation.

[35]  A. Fischer,et al.  A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection. , 2005, The Journal of clinical investigation.

[36]  U. Pannicke,et al.  A variant of SCID with specific immune responses and predominance of γδ T cells , 2005 .

[37]  R. Buckley.  Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. , 2004, Annual review of immunology.

[38]  A. Fischer,et al.  Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome. , 2001, Blood.

[39]  L. Notarangelo,et al.  Recombinase activating gene enzymes of lymphocytes , 2001, Current opinion in hematology.

[40]  A. Villa,et al.  N-terminal RAG1 frameshift mutations in Omenn's syndrome: internal methionine usage leads to partial V(D)J recombination activity and reveals a fundamental role in vivo for the N-terminal domains. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Sandro Santagata,et al.  Partial V(D)J Recombination Activity Leads to Omenn Syndrome , 1998, Cell.

[42]  U. Pannicke,et al.  RAG Mutations in Human B Cell-Negative SCID , 1996, Science.

[43]  D. Schatz,et al.  RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. , 1990, Science.

[44]  David Baltimore,et al.  The V(D)J recombination activating gene, RAG-1 , 1989, Cell.

[45]  L. Notarangelo,et al.  Defect of regulatory T cells in patients with Omenn syndrome. , 2010, The Journal of allergy and clinical immunology.

[46]  U. Pannicke,et al.  A variant of SCID with specific immune responses and predominance of gamma delta T cells. , 2005, The Journal of clinical investigation.

[47]  M. Gellert.  V(D)J recombination: RAG proteins, repair factors, and regulation. , 2002, Annual review of biochemistry.

[48]  D. Schatz,et al.  Factors and forces controlling V(D)J recombination. , 2001, Advances in immunology.

[49]  E. Brooks,et al.  V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. , 2001, Blood.